Retina industry insights from Alcon on display at Ophthalmology Innovation Summit

Video

Paul Hallen discusses the Retina Industry Insights panel at the Ophthalmology Innovation Summit in San Antonio, Texas.

Paul Hallen, Vice President, Global Head of Retina, Alcon, discusses the Retina Industry Insights panel at OIS in San Antonio, Texas. The panel discussion took place on October 7 at the Grand Hyatt San Antonio.

Mr. Hallen has been with Alcon since 1989, and has led the team through the transition from analog microscopes to NGENUITY 3D Digital Surgery. He also founded Retina Labs and has served as a consultant to NASA to aid with technologies to assess and protect the vision of astronauts pursuing a Mars expedition.

The American Society of Retina Specialists (ASRS) hosted its 39th Annual Scientific Meeting from October 8-12, 2021, at the JW Marriott San Antonio Hill Country Resort and Spa in San Antonio, Texas.

According to ASRS, its 2021 scientific program offered attendees innovations in retina science, clinical practice, and surgery with 148 papers, 165 posters, 46 papers on demand, and 69 films, as well as a wide range of networking opportunities and the chance to exchange ideas and perspectives with peers.

Related Content: Additional ASRS content | Retina | Inflammation & Infection

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
Related Content
A woman stands at a lectern delivering a presentation to an audience. She is viewed through the blur of the crowded audience. Image credit: ©as-artmedia – stock.adobe.com

Industry preview: Eye care companies announce presentations ahead of ASRS meeting

Sydney M Crago
July 16th 2024
Article

Companies in the retina space announced presentations ahead of the American Society of Retina Specialists meeting, to be held 17-20 July

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

A view from the water of Stockholm at dawn. Image credit: ©Sergii Figurnyi – stock.adobe.com

Preview: The American Society of Retina Specialists meets in Stockholm, Sweden

Lynda Charters
July 8th 2024
Article

Extended daylight hours and plentiful outdoor space make Stockholm a memorable destination for meeting attendees

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

A man undergoes an eye exam. An ophthalmologist shines a light into his eye. Image credit: ©sebra – stock.adobe.com

EMA issues positive CHMP opinion for faricimab (Vabysmo) in third indication retinal vein occlusion

Hattie Hayes
July 2nd 2024
Article

Faricimab is already approved in the EU and UK for neovascular age-related macular degeneration and diabetic macular oedema

A person at a desk administers a stamp that says "approved." Image credit: ©H_Ko – stock.adobe.com

US FDA approves biosimilar aflibercept-mrbb (Ahzantive)

Martin David Harp
July 2nd 2024
Article

The drug is a biosimilar for aflibercept 2 mg (Eylea)

© 2024 MJH Life Sciences

All rights reserved.